LEXXW vs LVS · rev $705.9K vs P/E 28, rev $6.74B
Lexaria Bioscience Corp (LEXXW) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
LEXXW currently screens at market cap $33.8M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the LEXXW and LVS stock pages for the full models.
Not investment advice.